[ON THE CAPACITY OF SODIUM DEHYDROCHOLATE TO INDUCE OCULAR HYPOTENSION].

G. Auricchio,M. Diotallevi

1963-10-01

Abstract:

What problem does this paper attempt to address?

The p53 tumor suppressor regulates AKR1B1 expression, a metastasis-promoting gene in breast cancer

Carolina Di Benedetto,Carla Borini Etichetti,Nabila Cocordano,Alejo Cantoia,Evelyn Arel Zalazar,Silvio Bicciato,Mauricio Menacho-Márquez,Germán Leandro Rosano,Javier Girardini

DOI: https://doi.org/10.3389/fmolb.2023.1145279

IF: 6.113

2023-09-15

Frontiers in Molecular Biosciences

Abstract:Alteration of metabolism in cancer cells is a central aspect of the mechanisms that sustain aggressive traits. Aldo–keto reductase 1 B1 (AKR1B1) catalyzes the reduction of several aldehydes to alcohols consuming NADPH. Nevertheless, the ability of AKR1B1 to reduce different substrates renders difficult to comprehensively ascertain its biological role. Recent evidence has implicated AKR1B1 in cancer; however, the mechanisms underlying its pro-oncogenic function remain largely unknown. In this work, we report that AKR1B1 expression is controlled by the p53 tumor suppressor. We found that breast cancer patients bearing wild-type TP53 have reduced AKR1B1 expression. In cancer cell lines, p53 reduced AKR1B1 mRNA and protein levels and repressed promoter activity in luciferase assays. Furthermore, chromatin immunoprecipitation assays indicated that p53 is recruited to the AKR1B1 promoter. We also observed that AKR1B1 overexpression promoted metastasis in the 4T1 orthotopic model of triple-negative breast cancer. Proteomic analysis of 4T1 cells overexpressing AKR1B1 showed that AKR1B1 exerts a marked effect on proteins related to metabolism, with a particular impact on mitochondrial function. This work provides novel insights on the link between the p53 pathway and metabolism in cancer cells and contributes to characterizing the alterations associated to the pathologic role of AKR1B1.

biochemistry & molecular biology
Expression of p53 in human adipose tissue correlates positively with FAS and BMI

Stephan Wueest,Chiara Scaffidi,Pim P. van Krieken,Nils K. Konrad,Christian Koch,Ioannis G. Lempesis,Jonas Fullin,Konstantinos N. Manolopoulos,Steffen Böttcher,Gijs H. Goossens,Matthias Blüher,Daniel Konrad

DOI: https://doi.org/10.1038/s41366-024-01691-4

2024-12-03

International Journal of Obesity

Abstract:Activation of Fas (CD95) in adipocytes inhibits browning and may contribute to body weight gain in mice. Moreover, Fas expression in white adipose tissue (WAT) correlates positively with body mass index (BMI) in humans. However, molecular pathways involved in the inhibitory effect of Fas on energy metabolism remain incompletely understood. Herein, we report that protein levels of the tumor suppressor p53 were reduced in primary white adipocytes of adipocyte-specific Fas-knockout mice. Moreover, Fas ligand (FasL) treatment increased p53 concentrations in cultured adipocytes and decreased mitochondrial oxygen consumption in control but not in p53-depleted cells, indicating that Fas activation reduces energy expenditure in a p53-dependent manner. In line, in differentiated human mesenchymal stem cells and WAT derived from different anatomical depots, FAS expression was positively associated with p53 . Furthermore, p53 expression in human subcutaneous and visceral WAT correlated positively with BMI, whereas its expression in visceral WAT was inversely associated with insulin sensitivity (as assessed by hyperinsulinemic-euglycemic clamp). Taken together, our data suggest that Fas regulates p53 expression in adipocytes, and may thereby affect body weight gain and insulin sensitivity.

endocrinology & metabolism,nutrition & dietetics
Functional Diversity of P53 in Human and Wild Animals

Yang Li,Mengchen Zhang,Xiaoli Xu,Yang Zhao,Mahanand Chatoo,Tao Zhu,Hong Deng,Eviatar Nevo,Ji-Zeng Du,Xuequn Chen

DOI: https://doi.org/10.3389/fendo.2019.00152

IF: 6.055

2019-01-01

Frontiers in Endocrinology

Abstract:The common understanding of p53 function is a genome guardian, which is activated by diverse stresses stimuli and mediates DNA repair, apoptosis, and cell cycle arrest. Increasing evidence has demonstrated p53 new cellular functions involved in abundant endocrine and metabolic response for maintaining homeostasis. However, TP53 is frequently mutant in human cancers, and the mutant p53 (Mut-p53) turns to an "evil" cancer-assistant. Mut-p53-induced epithelial-mesenchymal transition (EMT) plays a crucial role in the invasion and metastasis of endocrine carcinomas, and Mut-p53 is involved in cancer immune evasion by upregulating PD-L1 expression. Therefore, Mut-p53 is a valuable treatment target for malignant tumors. Targeting Mut-p53 in correcting sequence and conformation are increasingly concerned. Interestingly, in wild animals, p53 variations contribute to cancer resistant and high longevity. This review has discussed the multiple functions of p53 in health, diseases, and nature evolution, summarized the frequently mutant sites of p53, and the mechanisms of Mut-p53-mediated metastasis and immune evasion in endocrine cancers. We have provided a new insight for multiple roles of p53 in human and wild animals.
p53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment.

Xinbing Sui,Lijun Jin,Xuefeng Huang,Shumin Geng,Chao He,Xiaotong Hu

DOI: https://doi.org/10.4161/auto.7.6.14073

IF: 13.391

2011-01-01

Autophagy

Abstract:p53 as a tumor suppressor protein has been implicated in multiple aspects of biological processes, including apoptosis, cell cycle arrest, senescence, metabolism, differentiation and angiogenesis. Recently, several studies have shown that p53 can induce autophagy in both transcription-dependent and -independent manners. Nonetheless, p53 may also inhibit autophagy. In addition, p53 participates in homeostatic regulation of energy metabolism, oxidative stress and amino acid metabolism. Although the relationship between autophagy and p53 is quite complicated, and has not been well elucidated, p53 may underlie key aspects of metabolism and cancer biology. Thus, understanding the novel functions of p53 may allow us to develop new anticancer therapeutic approaches.
The Pathology of Congenital Ring Constrictions*

D. Browne

DOI: https://doi.org/10.1136/adc.32.166.517

1957-12-01

Archives of Disease in Childhood

Abstract:There is no agreement about the cause of the constrictions at birth on various parts of the human body. This paper suggests that they are due to the digits, limbs or the body itself penetrating to various degrees the amniotic membrane, with consequent concentric pressure on the developing tissues. The conditions necessary for a final testing of this hypothesis are laid down.
Skeletal muscle p53-depletion uncovers a mechanism of fuel usage suppression that enables efficient energy conservation

Georgia Lenihan-Geels,Francisco Garcia Carrizo,Marina Leer,Sabrina Gohlke,Moritz Oster,Sophie Pöhle-Kronawitter,Christiane Ott,Alexandra Chadt,Isabel N Reinisch,Markus Galhuber,Chen Li,Wenke Jonas,Markus Jähnert,Susanne Klaus,Hadi Al-Hasani,Tilman Grune,Annette Schürmann,Tobias Madl,Andreas Prokesch,Michael Schupp,Tim J Schulz

DOI: https://doi.org/10.1002/jcsm.13529

2024-07-15

Abstract:Background: The ability of skeletal muscle to respond adequately to changes in nutrient availability, known as metabolic flexibility, is essential for the maintenance of metabolic health and loss of flexibility contributes to the development of diabetes and obesity. The tumour suppressor protein, p53, has been linked to the control of energy metabolism. We assessed its role in the acute control of nutrient allocation in skeletal muscle in the context of limited nutrient availability. Methods: A mouse model with inducible deletion of the p53-encoding gene, Trp53, in skeletal muscle was generated using the Cre-loxP-system. A detailed analysis of nutrient metabolism in mice with control and knockout genotypes was performed under ad libitum fed and fasting conditions and in exercised mice. Results: Acute deletion of p53 in myofibres of mice activated catabolic nutrient usage pathways even under ad libitum fed conditions, resulting in significantly increased overall energy expenditure (+10.6%; P = 0.0385) and a severe nutrient deficit in muscle characterized by depleted intramuscular glucose and glycogen levels (-62,0%; P < 0.0001 and -52.7%; P < 0.0001, respectively). This was accompanied by changes in marker gene expression patterns of circadian rhythmicity and hyperactivity (+57.4%; P = 0.0068). These metabolic changes occurred acutely, within 2-3 days after deletion of Trp53 was initiated, suggesting a rapid adaptive response to loss of p53, which resulted in a transient increase in lactate release to the circulation (+46.6%; P = 0.0115) from non-exercised muscle as a result of elevated carbohydrate mobilization. Conversely, an impairment of proteostasis and amino acid metabolism was observed in knockout mice during fasting. During endurance exercise testing, mice with acute, muscle-specific Trp53 inactivation displayed an early exhaustion phenotype with a premature shift in fuel usage and reductions in multiple performance parameters, including a significantly reduced running time and distance (-13.8%; P = 0.049 and -22.2%; P = 0.0384, respectively). Conclusions: These findings suggest that efficient nutrient conservation is a key element of normal metabolic homeostasis that is sustained by p53. The homeostatic state in metabolic tissues is actively maintained to coordinate efficient energy conservation and metabolic flexibility towards nutrient stress. The acute deletion of Trp53 unlocks mechanisms that suppress the activity of nutrient catabolic pathways, causing substantial loss of intramuscular energy stores, which contributes to a fasting-like state in muscle tissue. Altogether, these findings uncover a novel function of p53 in the short-term regulation of nutrient metabolism in skeletal muscle and show that p53 serves to maintain metabolic homeostasis and efficient energy conservation.
p53 regulates lipid metabolism in cancer

Ling-Li Chen,Wen-Jun Wang

DOI: https://doi.org/10.1016/j.ijbiomac.2021.09.188

IF: 8.2

2021-12-01

International Journal of Biological Macromolecules

Abstract:Reprogrammed cell metabolism is a well-accepted hallmark of cancer. Metabolism changes provide energy and precursors for macromolecule biosynthesis to satisfy the survival needs of cancer cells. The specific changes in different aspects of lipid metabolism in cancer cells have been focused in recent years. These changes can affect cell growth, proliferation, differentiation and motility through affecting membranes synthesis, energy homeostasis and cell signaling. The tumor suppressor p53 plays vital roles in the control of cell proliferation, senescence, DNA repair, and cell death in cancer through various transcriptional and non-transcriptional activities. Accumulating evidences indicate that p53 also regulates cellular metabolism, which appears to contribute to its tumor suppressive functions. Particularly the role of p53 in regulating lipid metabolism has gained more and more attention in recent decades. In this review, we summarize recent advances in the function of p53 on lipid metabolism in cancer. Further understanding and research on the role of p53 in lipid metabolism regulation will provide a potential therapeutic window for cancer treatment.

polymer science,biochemistry & molecular biology,chemistry, applied
Adipocyte p53 coordinates the response to intermittent fasting by regulating adipose tissue immune cell landscape

Isabel Reinisch,Helene Michenthaler,Alba Sulaj,Elisabeth Moyschewitz,Jelena Krstic,Markus Galhuber,Ruonan Xu,Zina Riahi,Tongtong Wang,Nemanja Vujic,Melina Amor,Riccardo Zenezini Chiozzi,Martin Wabitsch,Dagmar Kolb,Anastasia Georgiadi,Lisa Glawitsch,Ellen Heitzer,Tim J. Schulz,Michael Schupp,Wenfei Sun,Hua Dong,Adhideb Ghosh,Anne Hoffmann,Dagmar Kratky,Laura C. Hinte,Ferdinand von Meyenn,Albert J. R. Heck,Matthias Blüher,Stephan Herzig,Christian Wolfrum,Andreas Prokesch

DOI: https://doi.org/10.1038/s41467-024-45724-y

IF: 16.6

2024-02-15

Nature Communications

Abstract:Abstract In obesity, sustained adipose tissue (AT) inflammation constitutes a cellular memory that limits the effectiveness of weight loss interventions. Yet, the impact of fasting regimens on the regulation of AT immune infiltration is still elusive. Here we show that intermittent fasting (IF) exacerbates the lipid-associated macrophage (LAM) inflammatory phenotype of visceral AT in obese mice. Importantly, this increase in LAM abundance is strongly p53 dependent and partly mediated by p53-driven adipocyte apoptosis. Adipocyte-specific deletion of p53 prevents LAM accumulation during IF, increases the catabolic state of adipocytes, and enhances systemic metabolic flexibility and insulin sensitivity. Finally, in cohorts of obese/diabetic patients, we describe a p53 polymorphism that links to efficacy of a fasting-mimicking diet and that the expression of p53 and TREM2 in AT negatively correlates with maintaining weight loss after bariatric surgery. Overall, our results demonstrate that p53 signalling in adipocytes dictates LAM accumulation in AT under IF and modulates fasting effectiveness in mice and humans.

multidisciplinary sciences
p53-Mediated Indirect Regulation on Cellular Metabolism: From the Mechanism of Pathogenesis to the Development of Cancer Therapeutics

Chen-Yun Wang,Chi-Hong Chao

DOI: https://doi.org/10.3389/fonc.2022.895112

IF: 4.7

2022-05-31

Frontiers in Oncology

Abstract:The transcription factor p53 is the most well-characterized tumor suppressor involved in multiple cellular processes, which has expanded to the regulation of metabolism in recent decades. Accumulating evidence reinforces the link between the disturbance of p53-relevant metabolic activities and tumor development. However, a full-fledged understanding of the metabolic roles of p53 and the underlying detailed molecular mechanisms in human normal and cancer cells remain elusive, and persistent endeavor is required to foster the entry of drugs targeting p53 into clinical use. This mini-review summarizes the indirect regulation of cellular metabolism by wild-type p53 as well as mutant p53, in which mechanisms are categorized into three major groups: through modulating downstream transcriptional targets, protein-protein interaction with other transcription factors, and affecting signaling pathways. Indirect mechanisms expand the p53 regulatory networks of cellular metabolism, making p53 a master regulator of metabolism and a key metabolic sensor. Moreover, we provide a brief overview of recent achievements and potential developments in the therapeutic strategies targeting mutant p53, emphasizing synthetic lethal methods targeting mutant p53 with metabolism. Then, we delineate synthetic lethality targeting mutant p53 with its indirect regulation on metabolism, which expands the synthetic lethal networks of mutant p53 and broadens the horizon of developing novel therapeutic strategies for p53 mutated cancers, providing more opportunities for cancer patients with mutant p53. Finally, the limitations and current research gaps in studies of metabolic networks controlled by p53 and challenges of research on p53-mediated indirect regulation on metabolism are further discussed.

oncology
P53 and Regulation of Tumor Metabolism

Peng Jiang,Wenjing Du,Xiaolu Yang

DOI: https://doi.org/10.4103/1477-3163.122760

2013-01-01

Journal of Carcinogenesis

Abstract:The tumor suppressor p53 plays a pre-eminent role in protecting against cancer, through its ability to sense various stresses and in turn invoke anti-proliferative and repair responses. Emerging evidence suggest that p53 is both a central sentinel for metabolic stresses and a master regulator of metabolic fluxes. This newly identified function of p53, along with the ability of p53 to induce senescence, appears to be crucial for the prevention of oncogenic transformation. A better understanding of the reciprocal regulation of p53 and metabolism, as well as p53-mediated connection between metabolism and senescence, may lead to the identification of valuable targets for tumor therapy.
p53 in survival, death and metabolic health: a lifeguard with a licence to kill

Flore Kruiswijk,Christiaan F. Labuschagne,Karen H. Vousden

DOI: https://doi.org/10.1038/nrm4007

IF: 113.915

2015-06-23

Nature Reviews Molecular Cell Biology

Abstract:Key PointsActivation of the transcription factor p53 in response to different types of cellular stress can lead to cell survival as well as cell elimination.Novel insights into the functions of p53 reveal that diverse mechanisms influence cell fate decisions upon p53 activation.p53 sustains metabolic health and homeostasis by allowing cells to adapt to transient metabolic and nutrient stress through the regulation of signalling pathways and by modulating transcription or the activity of metabolic enzymes.Basal levels of reactive oxygen species (ROS) are important for normal cellular processes, whereas excessive levels of ROS are deleterious. p53 promotes antioxidant activity under normal conditions to protect cells from ROS and promotes pro-oxidant activity under severe oxidative stress to eliminate damaged cells by inducing ROS.The survival functions of p53 may help to prevent tumour development, but persistence of these activities during malignant development may help to support cancer progression.To use manipulations of p53 activity in a therapeutic setting, whether for tumour suppression or in other pathologies, the context-dependent variability in the outcome of p53 activation needs to be carefully considered.

cell biology
Emerging Roles of the Tumor Suppressor p53 in Metabolism

Lili Yu,Meng Wu,Gaoyang Zhu,Yang Xu

DOI: https://doi.org/10.3389/fcell.2021.762742

IF: 5.5

2022-01-18

Frontiers in Cell and Developmental Biology

Abstract:Metabolism plays critical roles in maintaining the homeostasis of cells. Metabolic abnormalities are often considered as one of the main driving forces for cancer progression, providing energy and substrates of biosynthesis to support neoplastic proliferation effectively. The tumor suppressor p53 is well known for its roles in inducing cell cycle arrest, apoptosis, senescence and ferroptosis. Recently, emerging evidence has shown that p53 is also actively involved in the reprogramming of cellular metabolism. In this review, we focus on recent advances in our understanding of the interplay between p53 and metabolism of glucose, fatty acid as well as amino acid, and discuss how the deregulation of p53 in these processes could lead to cancer.

cell biology,developmental biology
Regulation of Metabolic Activity by p53

Jessica Flöter,Irem Kaymak,Almut Schulze

DOI: https://doi.org/10.3390/metabo7020021

IF: 4.1

2017-05-20

Metabolites

Abstract:Metabolic reprogramming in cancer cells is controlled by the activation of multiple oncogenic signalling pathways in order to promote macromolecule biosynthesis during rapid proliferation. Cancer cells also need to adapt their metabolism to survive and multiply under the metabolically compromised conditions provided by the tumour microenvironment. The tumour suppressor p53 interacts with the metabolic network at multiple nodes, mostly to reduce anabolic metabolism and promote preservation of cellular energy under conditions of nutrient restriction. Inactivation of this tumour suppressor by deletion or mutation is a frequent event in human cancer. While loss of p53 function lifts an important barrier to cancer development by deleting cell cycle and apoptosis checkpoints, it also removes a crucial regulatory mechanism and can render cancer cells highly sensitive to metabolic perturbation. In this review, we will summarise the major concepts of metabolic regulation by p53 and explore how this knowledge can be used to selectively target p53 deficient cancer cells in the context of the tumour microenvironment.

biochemistry & molecular biology
Targeting p53 pathways: mechanisms, structures, and advances in therapy

Haolan Wang,Ming Guo,Hudie Wei,Yongheng Chen

DOI: https://doi.org/10.1038/s41392-023-01347-1

IF: 39.3

2023-03-02

Signal Transduction and Targeted Therapy

Abstract:The TP53 tumor suppressor is the most frequently altered gene in human cancers, and has been a major focus of oncology research. The p53 protein is a transcription factor that can activate the expression of multiple target genes and plays critical roles in regulating cell cycle, apoptosis, and genomic stability, and is widely regarded as the "guardian of the genome". Accumulating evidence has shown that p53 also regulates cell metabolism, ferroptosis, tumor microenvironment, autophagy and so on, all of which contribute to tumor suppression. Mutations in TP53 not only impair its tumor suppressor function, but also confer oncogenic properties to p53 mutants. Since p53 is mutated and inactivated in most malignant tumors, it has been a very attractive target for developing new anti-cancer drugs. However, until recently, p53 was considered an "undruggable" target and little progress has been made with p53-targeted therapies. Here, we provide a systematic review of the diverse molecular mechanisms of the p53 signaling pathway and how TP53 mutations impact tumor progression. We also discuss key structural features of the p53 protein and its inactivation by oncogenic mutations. In addition, we review the efforts that have been made in p53-targeted therapies, and discuss the challenges that have been encountered in clinical development.

biochemistry & molecular biology,cell biology
The Dysfunctional MDM2–p53 Axis in Adipocytes Contributes to Aging-Related Metabolic Complications by Induction of Lipodystrophy

Zhuohao Liu,Leigang Jin,Jin-Kui Yang,Baile Wang,Kelvin K.L. Wu,Philip Hallenborg,Aimin Xu,Kenneth K.Y. Cheng

DOI: https://doi.org/10.2337/db18-0684

IF: 7.7

2018-08-21

Diabetes

Abstract:Profound loss and senescence of adipose tissues are hallmarks of advanced age, but the underlying cause and their metabolic consequences remain obscure. Proper function of the murine double minute 2 (MDM2)–p53 axis is known to prevent tumorigenesis and several metabolic diseases, yet its role in regulation of adipose tissue aging is still poorly understood. In this study, we show that the proximal p53 inhibitor MDM2 is markedly downregulated in subcutaneous white and brown adipose tissues of mice during aging. Genetic disruption of MDM2 in adipocytes triggers canonical p53-mediated apoptotic and senescent programs, leading to age-dependent lipodystrophy and its associated metabolic disorders, including type 2 diabetes, nonalcoholic fatty liver disease, hyperlipidemia, and energy imbalance. Surprisingly, this lipodystrophy mouse model also displays premature loss of physiological integrity, including impaired exercise capacity, multiple organ senescence, and shorter life span. Transplantation of subcutaneous fat rejuvenates the metabolic health of this aging-like lipodystrophy mouse model. Furthermore, senescence-associated secretory factors from MDM2-null adipocytes impede adipocyte progenitor differentiation via a non–cell-autonomous manner. Our findings suggest that tight regulation of the MDM2–p53 axis in adipocytes is required for adipose tissue dynamics and metabolic health during the aging process.

endocrinology & metabolism
Effects of heavy metals on the Ca(2+)-ATPase activity present in gill cell plasma-membrane of mussels (Mytilus galloprovincialis Lam.).

Aldo Viarengo,G. Mancinelli,M. Pertica,R. Fabbri,Mauro Orunesu

DOI: https://doi.org/10.1016/0742-8413(93)90223-8

1993-11-01

Abstract:
The p53 family orchestrates the regulation of metabolism: physiological regulation and implications for cancer therapy

Marco Napoli,Elsa R Flores

DOI: https://doi.org/10.1038/bjc.2016.384

IF: 9.075

2016-11-24

British Journal of Cancer

Abstract:The p53 family of transcription factors is essential to counteract tumour formation and progression. Although previously this was exclusively associated with the ability of the p53 family to induce cell cycle arrest and apoptosis, an increasing number of reports have now indisputably demonstrated that the tumour suppressive functions of the p53 family members also rely on their ability to control and regulate cellular metabolism and maintain cellular oxidative homeostasis. Here, we review how each p53 family member, including p63 and p73, controls metabolic pathways in physiological conditions, and how these mechanisms could be exploited to provide anticancer therapeutic opportunities.

oncology
P53 regulates mitochondrial biogenesis via transcriptionally induction of mitochondrial ribosomal protein L12

Yitong Han,Yi Liu,Junhui Zhen,Shaoshuai Hou,Bo Zhang,ZhengGuo Cui,Qiang Wan,Hong Feng

DOI: https://doi.org/10.1016/j.yexcr.2022.113249

IF: 4.145

2022-09-01

Experimental Cell Research

Abstract:The well-documented tumor suppressor p53 is also a major stress response factor for its diverse regulation on cellular energetics. However, the effect of p53 on mitochondrial biogenesis, which plays a predominant role in response to the elevated energy demands, appears to be pleiotropic in various conditions and has not reached agreement. Mitochondrial ribosomal protein L12 (MRPL12), reported as a bi-functional protein for its roles in both mitochondrial ribosomes and transcriptional complexes, is a core regulatory component in mitochondrial biogenesis. Here we proved that MRPL12 is transcriptionally regulated by p53. Furthermore, the p53/MRPL12 regulation of mitochondria is part of the signaling pathway that maintains the basal mitochondrial content and positively coordinates the mitochondrial biogenesis and oxidative phosphorylation (OXPHOS) in response to metabolic perturbation. Since p53 serves as the‘Guardian of the Genome’, our findings may revealed a new mechanism underlying the conditions when more ATP is warranted to maintain the genome integrity and cell survival. Therefore the pharmacological intervention or metabolic modulation (e.g., through fasting or exercise) of the p53/MRPL12 pathway promises to be a therapeutic approach that can safeguard health.

oncology,cell biology
Transcription factor p63, a member of the p53 family of tumour suppressors, regulates hepatic glucose metabolism

Gilles Mithieux

DOI: https://doi.org/10.1136/gutjnl-2022-327790

IF: 24.5

2023-02-08

Gut

Abstract:Transcription factors of the family p53 have emerged as an important set of tumour suppressors, able to regulate various cell functions like cell cycle arrest, differentiation, DNA repair, apoptosis that can all modulate the initiation or the progression of tumours.1 The close relationships between the biochemical pathways that regulate cell metabolism and cancer initiation are becoming increasingly well known.2 Consistently, out of the family, p53 has been reported to regulate body glucose metabolism, e.g. insulin sensitivity of the adipose tissue3 or hepatic gluconeogenesis and glycogen storage.4 Curiously, there was not much information about the role in the control of metabolism of p63, another key member of the family. However, the observation that mice lacking p63 develop obesity and altered glucose control and insulin resistance has suggested that this could be the case.5 P63 is widely expressed and exerts various...

gastroenterology & hepatology
KRAB-type Zinc-Finger Proteins PITA and PISA Specifically Regulate P53-Dependent Glycolysis and Mitochondrial Respiration

Shan Wang,Zhiqiang Peng,Siying Wang,Lihua Yang,Yuhan Chen,Xue Kong,Shanshan Song,Pei,Chunyan Tian,Hui Yan,Peipei Ding,Weiguo Hu,Cui Hua Liu,Xin Zhang,Fuchu He,Lingqiang Zhang

DOI: https://doi.org/10.1038/s41422-018-0008-8

2018-01-01

Abstract:Few p53 regulators participate in selective control of p53-mediated cellular metabolism. How p53-mediated aerobic and glycolytic pathways are negatively regulated remains largely unclear. Here, we identified two KRAB-type zinc-finger proteins, PITA (p53 inhibitor of TIGAR activation) and PISA (p53 inhibitor of SCO2 activation), as selective regulators of p53 in metabolic control. PITA and PISA interact with p53 and specifically suppress transcription of the glycolysis regulator TIGAR and the oxidation phosphorylation regulator SCO2, respectively. Importantly, PITA transgenic mice exhibited increased 6-phosphofructokinase 1 (PFK1) activity and an elevated glycolytic rate, whereas PISA transgenic mice had decreased cytochrome c oxidase activity and reduced mitochondrial respiration. In response to glucose starvation, PITA dissociates from p53, resulting in activation of p53 and induction of TIGAR, which inhibited aerobic glycolysis. Prolonged starvation leads to PISA dissociation from p53 and induction of SCO2 and p53-promoted mitochondrial respiration. The dynamic regulation of PITA and PISA upon metabolic stress is dependent on ATM kinase-mediated phosphorylation of PITA and PISA. Furthermore, in human colorectal cancers, the elevated expression of PITA and PISA correlates with cancer progression. Depletion of PITA or PISA in colorectal cancer cells reduced the cell proliferation, migration and invasion. These results identify PITA and PISA as selective regulators of p53-mediated glycolysis and mitochondrial respiration and provide novel insights into the role of p53 network in cell metabolic control.

[ON THE CAPACITY OF SODIUM DEHYDROCHOLATE TO INDUCE OCULAR HYPOTENSION].

The p53 tumor suppressor regulates AKR1B1 expression, a metastasis-promoting gene in breast cancer

Expression of p53 in human adipose tissue correlates positively with FAS and BMI

Functional Diversity of P53 in Human and Wild Animals

p53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment.

The Pathology of Congenital Ring Constrictions*

Skeletal muscle p53-depletion uncovers a mechanism of fuel usage suppression that enables efficient energy conservation

p53 regulates lipid metabolism in cancer

Adipocyte p53 coordinates the response to intermittent fasting by regulating adipose tissue immune cell landscape

p53-Mediated Indirect Regulation on Cellular Metabolism: From the Mechanism of Pathogenesis to the Development of Cancer Therapeutics

P53 and Regulation of Tumor Metabolism

p53 in survival, death and metabolic health: a lifeguard with a licence to kill

Emerging Roles of the Tumor Suppressor p53 in Metabolism

Regulation of Metabolic Activity by p53

Targeting p53 pathways: mechanisms, structures, and advances in therapy

The Dysfunctional MDM2–p53 Axis in Adipocytes Contributes to Aging-Related Metabolic Complications by Induction of Lipodystrophy

Effects of heavy metals on the Ca(2+)-ATPase activity present in gill cell plasma-membrane of mussels (Mytilus galloprovincialis Lam.).

The p53 family orchestrates the regulation of metabolism: physiological regulation and implications for cancer therapy

P53 regulates mitochondrial biogenesis via transcriptionally induction of mitochondrial ribosomal protein L12

Transcription factor p63, a member of the p53 family of tumour suppressors, regulates hepatic glucose metabolism

KRAB-type Zinc-Finger Proteins PITA and PISA Specifically Regulate P53-Dependent Glycolysis and Mitochondrial Respiration